amikacin liposomal 70.3 MG/ML Inhalation Suspension

RxNorm concept 2059184, clinical drug (scd). Prescribable name: amikacin liposomal 590 MG in 8.4 ML Inhalation Suspension.

RxCUI: 2059184
Term type: Clinical drug (SCD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2059184 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

amikacin 641

Other names

amikacin liposomal 590 MG per 8.4 ML Inhalation Suspension

Related concepts

amikacin liposomal 70.3 MG/ML (SCDC, consists of)
Inhalation Suspension (DF, has dose form)
amikacin liposomal 70.3 MG/ML Inhalation Suspension [Arikayce] (SBD, has tradename)

Linked data

NDCs

RxNorm links no NDCs to this concept.

Use it

Look up 2059184 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2059184 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2059184. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.